Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101,960,784
-
Total 13F shares
-
60,343,678
-
Share change
-
+1,036,665
-
Total reported value
-
$1,208,648,617
-
Put/Call ratio
-
34%
-
Price per share
-
$20.03
-
Number of holders
-
87
-
Value change
-
+$24,007,409
-
Number of buys
-
56
-
Number of sells
-
34
Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q3 2022
As of 30 Sep 2022,
Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,343,678 shares.
The largest 10 holders included
FMR LLC, Atlas Venture Life Science Advisors, LLC, RA CAPITAL MANAGEMENT, L.P., Canaan Partners XI LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, BlackRock Inc., FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, and STATE STREET CORP.
This page lists
87
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.